Citic Securities Investment and others jointly established Progenitec Diagnostics Biotechnology Co., Ltd. with a registered capital of approximately 110 million yuan.

According to the Tianyancha App, recently, Jiangsu Anto Medical Diagnostics Biotechnology Co., Ltd. was established, with Ren Yong as the legal representative. The registered capital is approximately 110 million RMB, and the business scope includes the production and sales of Class I medical devices, as well as the sales of Class II medical devices. Shareholder information shows that the company is jointly held by Nanjing Qiyi Technology Co., Ltd., Nanjing Xinjiye Technology Development Co., Ltd., HY2035 (Shenzhen) Equity Investment Fund Center, CITIC Securities Investment Co., Ltd., among others.